question_key
stringlengths 16
58
| relation
stringlengths 6
48
| question_template
stringlengths 29
90
| subject_cui
stringlengths 8
8
| subject_label
stringlengths 4
160
| correct_object_cui
stringlengths 8
8
| correct_object_label
stringlengths 3
204
| opa
stringlengths 7
150
| opb
stringlengths 3
204
| opc
stringlengths 4
221
| opd
stringlengths 5
166
| cop
int64 0
3
|
---|---|---|---|---|---|---|---|---|---|---|---|
C2981613::disease_excludes_finding | disease_excludes_finding | Which finding is specifically excluded in the diagnosis of disease {subj}? | C2981613 | Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7 | C0333868 | Severe cytologic atypia | Neurofibrillary degeneration (morphologic abnormality) | Trisomy 18 (morphologic abnormality) | Severe cytologic atypia | Squamous metaplasia | 2 |
C5420536::disease_excludes_finding | disease_excludes_finding | Which finding is specifically excluded in the diagnosis of disease {subj}? | C5420536 | Advanced Cervical Adenosquamous Carcinoma | C0277565 | Local disease | Regional enteritis | Basal pneumonia | Local disease | Nodal block | 2 |
C4725707::disease_excludes_normal_cell_origin | disease_excludes_normal_cell_origin | Which normal cell origin is specifically excluded in the disease {subj}? | C4725707 | Extracavitary Primary Effusion Lymphoma | C0032112 | Plasma Cells | Phagocytes | Cells.HLA-B27 | Plasma Cells | Plasma cells.abnormal marker pattern | 2 |
C0079773::disease_excludes_normal_cell_origin | disease_excludes_normal_cell_origin | Which normal cell origin is specifically excluded in the disease {subj}? | C0079773 | Lymphoma, T-Cell, Cutaneous | C0887899 | Myeloid Cells | Myeloid precursor cell | Myeloid Cells | Pre-B Lymphocytes | Blood Cells | 1 |
C5855556::disease_excludes_normal_cell_origin | disease_excludes_normal_cell_origin | Which normal cell origin is specifically excluded in the disease {subj}? | C5855556 | IgM Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Type | C1516097 | B lymphoblast | Monocytoid B-Lymphocyte | CYIG+ lymphocyte | B lymphoblast | Activated B-Lymphocyte | 2 |
C1335388::disease_excludes_normal_tissue_origin | disease_excludes_normal_tissue_origin | Which normal tissue origin is specifically excluded in the disease {subj}? | C1335388 | Peripheral Intraneural Angiosarcoma | C0014609 | Epithelium | Entire respiratory epithelium | Bile Duct Epithelium | Epidermis | Epithelium | 3 |
C5554988::disease_excludes_normal_tissue_origin | disease_excludes_normal_tissue_origin | Which normal tissue origin is specifically excluded in the disease {subj}? | C5554988 | Unresectable Myxofibrosarcoma | C0014609 | Epithelium | Epithelium | Epidermis proper | Epidermal Ridge | Transitional epithelium | 0 |
C0206717::disease_excludes_normal_tissue_origin | disease_excludes_normal_tissue_origin | Which normal tissue origin is specifically excluded in the disease {subj}? | C0206717 | Olfactory Neuroblastoma | C1708239 | Germinal Layer | Structure of germinal epithelium of ovary | Basal Domain of the Epithelium | Peyer Patch Germinal Center | Germinal Layer | 3 |
C4520724::disease_excludes_primary_anatomic_site | disease_excludes_primary_anatomic_site | Which primary anatomic site is specifically excluded in the disease {subj}? | C4520724 | Stage III Adult Soft Tissue Sarcoma AJCC v7 | C0262950 | Skeletal bone | Skeletal muscle structure of head | Skeleton of forearm | Skeletal bone | Bone structure of forearm | 2 |
C1332903::disease_excludes_primary_anatomic_site | disease_excludes_primary_anatomic_site | Which primary anatomic site is specifically excluded in the disease {subj}? | C1332903 | Cerebellar Vermis Medulloblastoma | C0037925 | Spinal Cord | Spinal cord posterior horn | Spinal nerve root NEC | Spinal Cord | Spinal cord tissue structure | 2 |
C1516417::disease_excludes_primary_anatomic_site | disease_excludes_primary_anatomic_site | Which primary anatomic site is specifically excluded in the disease {subj}? | C1516417 | Cervical Large Cell Neuroendocrine Carcinoma | C0460004 | Head and neck structure | External nose structure | Chest and abdominal vessels | Upper jaw region | Head and neck structure | 3 |
C5206840::disease_has_abnormal_cell | disease_has_abnormal_cell | Which abnormal cell type is characteristic of the disease {subj}? | C5206840 | Unresectable Oropharyngeal Squamous Cell Carcinoma | C1514101 | Neoplastic Squamous Cell | Neoplastic Cell | Primitive neuroblastic cell | Lymphosarcoma cell | Neoplastic Squamous Cell | 3 |
C2212014::disease_has_abnormal_cell | disease_has_abnormal_cell | Which abnormal cell type is characteristic of the disease {subj}? | C2212014 | Ovarian Mucinous Adenocarcinofibroma | C0334227 | Tumor cells, malignant | Entire endometrial glandular cell | Tumor cells, malignant | Vacuolated Malignant Fibroblast | Neoplastic Polygonal Cell | 1 |
C2825773::disease_has_abnormal_cell | disease_has_abnormal_cell | Which abnormal cell type is characteristic of the disease {subj}? | C2825773 | Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor | C1514104 | Neoplastic Stromal Cell | Endocrine-Stromal Cell | Primitive neuroblastic cell | Neoplastic Epithelial Polygonal Cell | Neoplastic Stromal Cell | 3 |
C2347926::disease_has_associated_anatomic_site | disease_has_associated_anatomic_site | Which anatomic site is associated with the disease {subj}? | C2347926 | Refractory Spinal Cord Neoplasm | C0037925 | Spinal Cord | Spinal nerve root S1 | Spinal Cord | Spinal cord posterior horn | Cervical Spinal Nerve Root | 1 |
C0033375::disease_has_associated_anatomic_site | disease_has_associated_anatomic_site | Which anatomic site is associated with the disease {subj}? | C0033375 | Prolactinoma | C0149543 | Base of skull structure | Base of skull structure | Orbital complex of bones - floor | Base of cochlear canal | Base of cochlear duct | 0 |
C1520094::disease_has_associated_anatomic_site | disease_has_associated_anatomic_site | Which anatomic site is associated with the disease {subj}? | C1520094 | Vulvar Sebaceous Carcinoma | C1261210 | Reproductive system | Reproductive system | Skeletal system | Arterial system | Digestive system subdivision | 0 |
C0279748::disease_has_associated_disease | disease_has_associated_disease | Which other disease is associated with the disease {subj}? | C0279748 | Undifferentiated carcinoma of nasopharynx | C0042769 | Virus Diseases | B Virus Infection | Flavivirus Infections | Virus Diseases | Coronaviridae Infections | 2 |
C1335509::disease_has_associated_disease | disease_has_associated_disease | Which other disease is associated with the disease {subj}? | C1335509 | Prostate Kaposi Sarcoma | C0042769 | Virus Diseases | B Virus Infection | Filoviridae Infections | Virus Diseases | Pestivirus Infections | 2 |
C2986686::disease_has_associated_disease | disease_has_associated_disease | Which other disease is associated with the disease {subj}? | C2986686 | Ann Arbor Stage IV AIDS-Related Lymphoma | C0009450 | Communicable Diseases | Immune System Diseases | Opportunistic Infections | Communicable Diseases | Pneumonia in bacterial diseases classified elsewhere | 2 |
C0302592::disease_has_associated_gene | disease_has_associated_gene | Which gene is associated with the disease {subj}? | C0302592 | Cervix carcinoma | C2826017 | MIR218-1 wt Allele | MIR218-1 wt Allele | MIR373 wt Allele | MIR191 wt Allele | MIR135B wt Allele | 0 |
C0279628::disease_has_associated_gene | disease_has_associated_gene | Which gene is associated with the disease {subj}? | C0279628 | Adenocarcinoma Of Esophagus | C1332804 | CTSB gene | LTB gene | CTSB gene | SPIB gene | CTNS gene | 1 |
C0002395::disease_has_associated_gene | disease_has_associated_gene | Which gene is associated with the disease {subj}? | C0002395 | Alzheimer's Disease | C1705380 | ZFYVE9 wt Allele | WDFY2 wt Allele | SIGLEC9 wt Allele | ARHGEF10 wt Allele | ZFYVE9 wt Allele | 3 |
C5238468::disease_has_finding | disease_has_finding | Which finding is characteristic of the disease {subj}? | C5238468 | Locally Advanced Neuroendocrine Neoplasm | C0277565 | Local disease | Disseminated scars | Burn shock | Local disease | Bone destruction | 2 |
C4764032::disease_has_finding | disease_has_finding | Which finding is characteristic of the disease {subj}? | C4764032 | Recurrent B-Cell Prolymphocytic Leukemia | C0277556 | Recurrent disease | Recurrent phimosis | Recurrent disease | Recurrent infections, mild | Relapsing Fever | 1 |
C1335035::disease_has_finding | disease_has_finding | Which finding is characteristic of the disease {subj}? | C1335035 | Non-Destructive Post-Transplant Lymphoproliferative Disorder | C0021051 | Immunologic Deficiency Syndromes | Immunologic Deficiency Syndromes | Hyper-IgM Immunodeficiency Syndrome, Type 1 | Simian Acquired Immunodeficiency Syndrome | Immune System Diseases | 0 |
C0677689::disease_has_molecular_abnormality | disease_has_molecular_abnormality | Which molecular abnormality is characteristic of the disease {subj}? | C0677689 | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | C1516672 | Clonal Immunoglobulin Gene Rearrangement | Absence of Biallelic TCRgamma Deletion | Clonal Immunoglobulin Gene Rearrangement | FEV Gene Rearrangement | IGH Gene Rearrangement | 1 |
C5670614::disease_has_molecular_abnormality | disease_has_molecular_abnormality | Which molecular abnormality is characteristic of the disease {subj}? | C5670614 | Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated | C4528702 | DICER1 Gene Mutation | Deleterious DICER1 Gene Mutation | DICER1 Gene Mutation | DOT1L Gene Mutation | DIS3 Gene Mutation | 1 |
C0281700::disease_has_molecular_abnormality | disease_has_molecular_abnormality | Which molecular abnormality is characteristic of the disease {subj}? | C0281700 | Stage I Childhood Burkitt Lymphoma | C1516673 | Clonal Immunoglobulin Heavy Chain Gene Rearrangement | Absence of Biallelic TCRgamma Deletion | IGK Gene Rearrangement | T-Cell Receptor Gene Rearrangement | Clonal Immunoglobulin Heavy Chain Gene Rearrangement | 3 |
C5669728::disease_has_normal_cell_origin | disease_has_normal_cell_origin | From which normal cell type does the disease {subj} originate? | C5669728 | Extramedullary Disease in Multiple Myeloma Involving the Skin | C1511241 | Bone Marrow-Homing Plasma Cell | Bone Marrow-Homing Plasma Cell | Mobilized Peripheral Blood Stem Cell | Neoplastic Medium-Sized Lymphocyte | Neoplastic Small to Medium-Sized B-Lymphocyte Resembling a Centrocyte | 0 |
C4682696::disease_has_normal_cell_origin | disease_has_normal_cell_origin | From which normal cell type does the disease {subj} originate? | C4682696 | Stage IIB Penile Cancer AJCC v8 | C0014597 | Epithelial Cells | Ciliated epithelial cell | Epithelial Cells | Endocrine Cells | Malignant Myoepithelial Cell | 1 |
C5855486::disease_has_normal_cell_origin | disease_has_normal_cell_origin | From which normal cell type does the disease {subj} originate? | C5855486 | B Acute Lymphoblastic Leukemia with HLF Rearrangement | C0024264 | Lymphocyte | CD105+ lymphocyte | HLE+ lymphocyte | Lymphocyte | B-Lymphocytes, Regulatory | 2 |
C3146256::disease_has_normal_tissue_origin | disease_has_normal_tissue_origin | From which normal tissue does the disease {subj} originate? | C3146256 | Stage II Rectal Cancer AJCC v7 | C0014609 | Epithelium | Oral epithelium tissue specimen | Stratified squamous epithelium | Epidermal basement zone | Epithelium | 3 |
C4727196::disease_has_normal_tissue_origin | disease_has_normal_tissue_origin | From which normal tissue does the disease {subj} originate? | C4727196 | Recurrent Gastroesophageal Junction Adenocarcinoma | C0014609 | Epithelium | Endothelium | Epidermal Ridge | Epithelium | Ductal Epithelium | 2 |
C1292772::disease_has_normal_tissue_origin | disease_has_normal_tissue_origin | From which normal tissue does the disease {subj} originate? | C1292772 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | C0229619 | Hemopoietic tissue | All bone marrow of bone organ | Hemopoietic tissue | Entire transplanted bone marrow | Genitourinary lymphoid tissue | 1 |
C4763829::disease_has_primary_anatomic_site | disease_has_primary_anatomic_site | What is the primary anatomic site of the disease {subj}? | C4763829 | Metastatic Bladder Plasmacytoid Urothelial Carcinoma | C1508753 | Urinary system | Skeletal system.peripheral | Articular system | Urinary system | Entire genitourinary system | 2 |
C1710249::disease_has_primary_anatomic_site | disease_has_primary_anatomic_site | What is the primary anatomic site of the disease {subj}? | C1710249 | Superficial Epithelioma with Sebaceous Differentiation | C0036505 | Sebaceous Glands | Duct of sebaceous gland | Sebaceous Glands | Sebaceous lobule | Sebaceous gland of areola | 1 |
C3899978::disease_has_primary_anatomic_site | disease_has_primary_anatomic_site | What is the primary anatomic site of the disease {subj}? | C3899978 | BCLC Stage C Adult Hepatocellular Carcinoma | C0012240 | Gastrointestinal system | Respiratory system subdivision | Upper digestive tract NEC | Gastrointestinal system | Entire digestive system | 2 |
C4553846::disease_is_stage | disease_is_stage | For which disease is {subj} a stage? | C4553846 | Stage IV Thyroid Gland Papillary Carcinoma AJCC v8 | C4683415 | Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage | Stage I Differentiated Thyroid Gland Carcinoma AJCC v8 | Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7 | Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7 | Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage | 3 |
C4683425::disease_is_stage | disease_is_stage | For which disease is {subj} a stage? | C4683425 | Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8 | C4683413 | Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 Stage | Stage II Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8 | Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8 | Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8 | Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 Stage | 3 |
C4553875::disease_is_stage | disease_is_stage | For which disease is {subj} a stage? | C4553875 | Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8 | C4683415 | Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage | Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 | Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8 | Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8 | Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage | 3 |
C1709312::disease_mapped_to_gene | disease_mapped_to_gene | Which gene is mapped to the disease {subj}? | C1709312 | Oncocytic Variant Thyroid Gland Papillary Carcinoma | C1847162 | GOLGA5/RET Fusion Gene | HMGA2/LHFP Fusion Gene | HMGA2/CCNB1IP1 Fusion Gene | TFG/NTRK1 Fusion Gene | GOLGA5/RET Fusion Gene | 3 |
C1332471::disease_mapped_to_gene | disease_mapped_to_gene | Which gene is mapped to the disease {subj}? | C1332471 | Benign Anal Granular Cell Tumor | C1412687 | ATP6AP1 gene | NCKAP1 gene | ATP6AP1 gene | CPA6 gene | CPA1 gene | 1 |
C5854746::disease_mapped_to_gene | disease_mapped_to_gene | Which gene is mapped to the disease {subj}? | C5854746 | Childhood Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1 | C1847677 | NSD1/NUP98 FUSION GENE | HOXD11/NUP98 FUSION GENE | NSD1/NUP98 FUSION GENE | MESDC2/SENP1 FUSION GENE | HOXA9/NUP98 FUSION GENE | 1 |
C1336015::disease_may_have_abnormal_cell | disease_may_have_abnormal_cell | Which abnormal cell type may be found in the disease {subj}? | C1336015 | Smoldering Adult T-Cell Leukemia/Lymphoma | C1514093 | Neoplastic Small T-Lymphocyte | Neoplastic T-Cell Large Granular Lymphocyte | Neoplastic Small T-Prolymphocyte | Tumor Associated Lymphocyte | Neoplastic Small T-Lymphocyte | 3 |
C5668167::disease_may_have_abnormal_cell | disease_may_have_abnormal_cell | Which abnormal cell type may be found in the disease {subj}? | C5668167 | Pericardial Primary Effusion Lymphoma | C1513927 | Neoplastic B-Immunoblast | Neoplastic Follicle Center B-Cell | Neoplastic Granulocyte | Neoplastic B-Immunoblast | Neoplastic Myeloid Cell | 2 |
C0855142::disease_may_have_abnormal_cell | disease_may_have_abnormal_cell | Which abnormal cell type may be found in the disease {subj}? | C0855142 | Nodal marginal zone B-cell lymphoma stage I | C1514058 | Neoplastic Plasma Cell | Neoplastic Glial Cell | Neoplastic Melanocyte | Neoplastic Endocrine Cell | Neoplastic Plasma Cell | 3 |
C0855184::disease_may_have_associated_disease | disease_may_have_associated_disease | Which other disease may be associated with the disease {subj}? | C0855184 | Testicular choriocarcinoma stage III | C0010417 | Cryptorchidism | Indeterminate sex and pseudohermaphroditism | Cryptorchidism | Opodidymus | Hologastroschisis | 1 |
C5206775::disease_may_have_associated_disease | disease_may_have_associated_disease | Which other disease may be associated with the disease {subj}? | C5206775 | Refractory Kidney Medullary Carcinoma | C0037054 | Sickle Cell Trait | hemoglobinopathy trait SS | Sickle Cell Trait | Sickle cell arthropathy | Sickle cell beta plus thalassemia | 1 |
C4725616::disease_may_have_associated_disease | disease_may_have_associated_disease | Which other disease may be associated with the disease {subj}? | C4725616 | Refractory Ovarian Endometrioid Adenocarcinoma | C0476089 | Endometrial Carcinoma | Type II Endometrial Adenocarcinoma | Recurrent Endometrial Undifferentiated Carcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Endometrial Carcinoma | 3 |
C1333842::disease_may_have_cytogenetic_abnormality | disease_may_have_cytogenetic_abnormality | Which cytogenetic abnormality may be present in the disease {subj}? | C1333842 | Grade 3 Cutaneous Follicular Lymphoma | C1515604 | del(6q23) | del(6p21) | del(6q23) | del(8p12p21) | del(11q22.3) | 1 |
C4763841::disease_may_have_cytogenetic_abnormality | disease_may_have_cytogenetic_abnormality | Which cytogenetic abnormality may be present in the disease {subj}? | C4763841 | Metastatic Bladder Giant Cell Urothelial Carcinoma | C1517979 | Loss of Chromosome 2q | Loss of Chromosome 20 | Chromosome 15q, partial deletion | Loss of Chromosome 2q | Chromosome 5q31-33 Deletion | 2 |
C1332997::disease_may_have_cytogenetic_abnormality | disease_may_have_cytogenetic_abnormality | Which cytogenetic abnormality may be present in the disease {subj}? | C1332997 | Childhood T Lymphoblastic Leukemia/Lymphoma | C1515789 | t(7;9)(q34;q34.3) | t(3;3)(q21.3;q26.2) | t(7;9)(q34;q34.3) | t(13;22)(q22;q13.3) | t(1;19)(q23;p13.3) | 1 |
C1334249::disease_may_have_finding | disease_may_have_finding | Which finding may be present in the disease {subj}? | C1334249 | Intraductal Micropapillary Breast Carcinoma | C0520594 | Breast Microcalcification | Breast Microcalcification | Cervical Microglandular Hyperplasia | Cortical calcifications | Calcified granuloma | 0 |
C5237826::disease_may_have_finding | disease_may_have_finding | Which finding may be present in the disease {subj}? | C5237826 | Advanced Colorectal Adenocarcinoma | C0024050 | Lower gastrointestinal hemorrhage | Other neonatal gastrointestinal hemorrhage | Duodenal hemorrhage | Gastrointestinal bleeding neonatal | Lower gastrointestinal hemorrhage | 3 |
C1519915::disease_may_have_finding | disease_may_have_finding | Which finding may be present in the disease {subj}? | C1519915 | Vaginal Adenosquamous Carcinoma | C2979982 | Vaginal Hemorrhage | Vaginal Hemorrhage | Hemorrhoidal Hemorrhage | Genital hemorrhage | Hemorrhage of tunica vaginalis | 0 |
C1512749::disease_may_have_molecular_abnormality | disease_may_have_molecular_abnormality | Which molecular abnormality may be present in the disease {subj}? | C1512749 | Invasive Bladder Urothelial Carcinoma with Trophoblastic Differentiation | C3266989 | H-ras gene mutation | KRAS Exon 3 Mutation | Checkpoint kinase 2 gene mutation | NRAS Gene Amplification | H-ras gene mutation | 3 |
C4743673::disease_may_have_molecular_abnormality | disease_may_have_molecular_abnormality | Which molecular abnormality may be present in the disease {subj}? | C4743673 | Digestive System Small Cell Neuroendocrine Carcinoma | C1515171 | TP53 Gene Inactivation | Deleterious TP53 Gene Mutation | Inactivating RAD51B Gene Mutation | TP53 Gene Inactivation | TGFBR2 Gene Inactivation | 2 |
C1334052::disease_may_have_molecular_abnormality | disease_may_have_molecular_abnormality | Which molecular abnormality may be present in the disease {subj}? | C1334052 | Human Papillomavirus-Related Cervical Squamous Cell Carcinoma | C1512127 | HER2 gene amplification | HER2 gene amplification | TERT Deficiency | BLyS polymorphism | Hypermelanosis due to hormonal factor | 0 |
C5401025::disposition_of | disposition_of | Which of the following is {subj} a disposition of? | C5401025 | Estrogen receptor agonist (disposition) | C0059668 | estrone sulfate | estrone sulfate | butacaine sulfate | estradiol valerate compounding powder | nomegestrol and estrogen | 0 |
C5434066::disposition_of | disposition_of | Which of the following is {subj} a disposition of? | C5434066 | Alpha-adrenergic and beta-adrenergic agonist (disposition) | C0304430 | pseudoephedrine hydrochloride | pseudoephedrine hydrochloride | aminacrine hydrochloride | Methscopolamine nitrate + pseudoephedrine hydrochloride | cinnamedrine hydrochloride | 0 |
C3853002::disposition_of | disposition_of | Which of the following is {subj} a disposition of? | C3853002 | Androgen Synthesis Inhibitors | C5686001 | Steroidal androgen synthesis inhibitor | testosterone cypionate compounding powder | Calcium antacid compound combinations | Steroidal androgen synthesis inhibitor | Testosterone esters | 2 |
C0185622::do_not_code_with | do_not_code_with | Which of the following should not be coded with {subj}? | C0185622 | Open treatment of fracture of orbit, except blowout; with implant | C1609555 | Irrigation of implanted venous access device for drug delivery systems | Revision of implantable venous access port | Irrigation of implanted venous access device for drug delivery systems | Implantation of electronic stimulator into urinary bladder | Fluoroscopy guided removal of implantable venous access device | 1 |
C0197419::do_not_code_with | do_not_code_with | Which of the following should not be coded with {subj}? | C0197419 | Corneal wedge resection for correction of surgically induced astigmatism | C1609555 | Irrigation of implanted venous access device for drug delivery systems | Irrigation of ventricular catheter | Accessing of implantable venous access port | Implantation of spinal drug delivery reservoir | Irrigation of implanted venous access device for drug delivery systems | 3 |
C0812502::do_not_code_with | do_not_code_with | Which of the following should not be coded with {subj}? | C0812502 | Laparoscopy, abdomen, peritoneum, and omentum, diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure) | C1736652 | Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less | Total hysterectomy via vaginal approach using intrafascial technique | Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less | laparoscopic vaginal hysterectomy with repair of cystocele and rectocele | laparoscopy with fulguration of gynecologic lesions of uterine surface | 1 |
C0695240::due_to | due_to | Which of the following is {subj} due to? | C0695240 | Mechanical complication of gastrostomy | C0017196 | Gastrostomy | Gastrostomy | Button gastrostomy feeding | Hepatogastrostomy | Gastroenterostomy | 0 |
C4040068::due_to | due_to | Which of the following is {subj} due to? | C4040068 | Hepatic coma due to acute hepatitis C | C0400914 | Acute hepatitis C | Hepatitis with hepatic coma | Chronic viral hepatitis D | Acute hepatitis C | Acute hepatopathy | 2 |
C0410706::due_to | due_to | Which of the following is {subj} due to? | C0410706 | Osteoporotic kyphosis | C0029456 | Osteoporosis | Low turnover osteopathy | Osteopenia or osteoporosis | Osteoporosis | Osteophyte | 2 |
C3887685::enzyme_metabolizes_chemical_or_drug | enzyme_metabolizes_chemical_or_drug | Which chemical or drug is metabolized by the enzyme {subj}? | C3887685 | Cytochrome P450 2D6, human | C0282321 | propranolol hydrochloride | alprenolol hydrochloride | celiprolol hydrochloride | tulobuterol hydrochloride | propranolol hydrochloride | 3 |
C0535996::enzyme_metabolizes_chemical_or_drug | enzyme_metabolizes_chemical_or_drug | Which chemical or drug is metabolized by the enzyme {subj}? | C0535996 | CYP3A5 protein, human | C0006462 | buspirone | profenamine | buspirone | Doprin | Buspirone only product | 1 |
C1142644::enzyme_metabolizes_chemical_or_drug | enzyme_metabolizes_chemical_or_drug | Which chemical or drug is metabolized by the enzyme {subj}? | C1142644 | cytochrome P450 3A4 protein, human | C0085170 | astemizole | astemizole | terizidone | piminodine | tolazamide | 0 |
C1517178::eo_disease_maps_to_human_disease | eo_disease_maps_to_human_disease | Which human disease does the experimental organism disease {subj} map to? | C1517178 | Fibroma of the Mouse Skin | C0016045 | fibroma | Recurrent fibromatosis | Fascial fibroma | fibroma | fetal myxolipoma | 2 |
C1522089::eo_disease_maps_to_human_disease | eo_disease_maps_to_human_disease | Which human disease does the experimental organism disease {subj} map to? | C1522089 | Adenoma of the Mouse Pulmonary System | C0001430 | Adenoma | Carcinofibroma | Solid carcinoma | Adenoma | Flat adenoma | 2 |
C1517177::eo_disease_maps_to_human_disease | eo_disease_maps_to_human_disease | Which human disease does the experimental organism disease {subj} map to? | C1517177 | Fibroma of the Mouse Intestinal Tract | C0017185 | Gastrointestinal Neoplasms | Gastrointestinal Neoplasms | Gastrointestinal Carcinoid Tumor | Jejunal Neoplasms | Gastrointestinal Stromal Tumors | 0 |
C1826983::exhibited_by | exhibited_by | Which of the following exhibits {subj}? | C1826983 | 5-methyltetrahydrofolate-homocysteine methyltransferase reductase activity | C1453956 | MTRR protein, human | MUSK protein, human | LTF protein, human | MTRR protein, human | TPR protein, human | 2 |
C1149833::exhibited_by | exhibited_by | Which of the following exhibits {subj}? | C1149833 | feruloyl esterase activity | C0117605 | feruloyl esterase | 2-ethylmalate synthase | vanillyl-alcohol oxidase | benzoyl-CoA reductase | feruloyl esterase | 3 |
C1151783::exhibited_by | exhibited_by | Which of the following exhibits {subj}? | C1151783 | methylenetetrahydrofolate reductase NADPH activity | C0066357 | Methylenetetrahydrofolate reductase (NADPH) | Aldose-6-phosphate reductase (NADPH) | CoA-disulfide reductase (NADH) | Methylenetetrahydrofolate reductase (NADPH) | Protein-disulfide reductase (NAD(P)H) | 2 |
C1439099::exhibits | exhibits | Which of the following is exhibited by {subj}? | C1439099 | CHST15 protein, human | C1325240 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity | positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity | formate C-acetyltransferase activity | UDP-glucose:glycoprotein glucosyltransferase activity | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity | 3 |
C1456416::exhibits | exhibits | Which of the following is exhibited by {subj}? | C1456416 | MAPK13 protein, human | C1150590 | SAP kinase 4 activity | SAP kinase 4 activity | protein kinase A signaling | negative regulation of protein kinase B signaling | protein kinase regulator activity | 0 |
C2001855::exhibits | exhibits | Which of the following is exhibited by {subj}? | C2001855 | EPHX1 protein, human | C2247484 | cis-stilbene-oxide hydrolase activity | diacetyl reductase ((R)-acetoin forming) activity | cis-stilbene-oxide hydrolase activity | 5'-hydroxyaverantin dehydrogenase activity | all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity | 1 |
C0585526::finding_method_of | finding_method_of | Which of the following uses {subj} as a finding method? | C0585526 | Exploration of colon | C2182884 | descending colon procedure manual abdominal exploration noting liver nodules | Sigmoid colectomy and exteriorisation of bowel NEC | Left hemicolectomy and exteriorisation of bowel NEC | descending colon procedure manual abdominal exploration noting liver nodules | Emergency excision of abnormal appendix NEC | 2 |
C1536105::finding_method_of | finding_method_of | Which of the following uses {subj} as a finding method? | C1536105 | Computed Tomography Angiography | C3694981 | CT angiography of head: aneurysm in right posterior communicating artery | CT angiography of head: aneurysm in right posterior communicating artery | angiography of cerebral portion of right carotid artery | fluoroscopic angiography of cerebral artery and left internal carotid artery | fluoroscopic angiography of cerebral artery with right carotid artery with IA contrast | 0 |
C0412716::finding_method_of | finding_method_of | Which of the following uses {subj} as a finding method? | C0412716 | Magnetic resonance imaging of ankle | C5765162 | MRI of tibiocalcaneal ligament | MRI of calcaneus | MRI of acromioclavicular joint | MRI of tibiocalcaneal ligament | MRI of calcaneus, talus, navicular and cuboid bones of foot | 2 |
C0032005::finding_site_of | finding_site_of | Which condition or procedure has {subj} as a finding site? | C0032005 | Pituitary Gland | C5568640 | Xanthomatous hypophysitis | Pseudomembranous stomatitis | Xanthomatous hypophysitis | Palmoplantar hypohidrosis | Secondary syphilitic osteopathy | 1 |
C0000726::finding_site_of | finding_site_of | Which condition or procedure has {subj} as a finding site? | C0000726 | Abdomen | C0206646 | Fibromatosis, Abdominal | Fibromatosis, Abdominal | Intra-Abdominal Lymphangioma | Endometrioid adenofibroma, malignant | Cystadenoma, Papillary | 0 |
C0700038::finding_site_of | finding_site_of | Which condition or procedure has {subj} as a finding site? | C0700038 | Female Reproductive System | C0346170 | Serous cystadenoma of ovary | Schneiderian carcinoma of cervix | Mucinous adenocarcinoma of appendix | Serous cystadenoma of ovary | Papillary serous cystadenoma | 2 |
C1706514::gene_associated_with_disease | gene_associated_with_disease | Which disease is associated with the gene {subj}? | C1706514 | GNAI2 wt Allele | C0032000 | Pituitary Adenoma | Childhood Parathyroid Gland Adenoma | Pituitary Adenoma | Primary pituitary carcinoma | Pituitary Neoplasms | 1 |
C2825749::gene_associated_with_disease | gene_associated_with_disease | Which disease is associated with the gene {subj}? | C2825749 | MIRLET7G wt Allele | C0684249 | Carcinoma of lung | Carcinoma of lung | Primary solid carcinoma of lung | Carcinoma of upper gum | Primary carcinoma of penis | 0 |
C1416655::gene_associated_with_disease | gene_associated_with_disease | Which disease is associated with the gene {subj}? | C1416655 | KIT gene | C0205851 | Germ cell tumor | Extragonadal primary germ cell cancer | Germ cell tumor | Ovarian germ cell polyembryoma | Testicular gonadoblastoma | 1 |
C1336804::gene_encodes_gene_product | gene_encodes_gene_product | Which gene product is encoded by the gene {subj}? | C1336804 | Transforming Growth Factor-Beta Family Gene | C0053932 | Bone Morphogenetic Proteins | Eosinophil Major Basic Protein | Bone Morphogenetic Proteins | MAGE-A1/MAGE-A3/NY-ESO-1 Peptides Vaccine | Heparan Sulfate Proteoglycans | 1 |
C0017362::gene_encodes_gene_product | gene_encodes_gene_product | Which gene product is encoded by the gene {subj}? | C0017362 | Genes, Regulator | C3254737 | LRRTM2 protein, human | SEphB4-HSA | BCDX2 Complex | rca protein, plant | LRRTM2 protein, human | 3 |
C1334166::gene_encodes_gene_product | gene_encodes_gene_product | Which gene product is encoded by the gene {subj}? | C1334166 | Immunoprotein Gene | C1870106 | Immunoglobulin Lambda-Like Polypeptide 1, human | Virus-specific Hyperimmune Globulins | Immune Globulin (Human) | Secretory Immunoglobulin A | Immunoglobulin Lambda-Like Polypeptide 1, human | 3 |
C1709988::gene_in_chromosomal_location | gene_in_chromosomal_location | What is the chromosomal location of the gene {subj}? | C1709988 | SMARCD2 wt Allele | C1520781 | 17q23-q24 | 14q23-q24.1 | 3q21-q28 | 17q23-q24 | 4q26-q32 | 2 |
C3538709::gene_in_chromosomal_location | gene_in_chromosomal_location | What is the chromosomal location of the gene {subj}? | C3538709 | DDX3X wt Allele | C1520174 | Xp11.3-p11.23 | Xp11.3-p11.23 | 3p24.1-p22 | 1p36.2-p36.12 | 17p11.1 | 0 |
C1705990::gene_in_chromosomal_location | gene_in_chromosomal_location | What is the chromosomal location of the gene {subj}? | C1705990 | LGALS8 wt Allele | C1521015 | 1q42-q43 | 13q12-q13 | Xq11-q13 | 1q42-q43 | 1p32-q12 | 2 |
C1708291::gene_involved_in_molecular_abnormality | gene_involved_in_molecular_abnormality | In which molecular abnormality is the gene {subj} involved? | C1708291 | CDC73 gene | C1708292 | CDC73 Gene Mutation | CDC73 Gene Mutation | PCDH19 gene mutation | JAK Family Gene Mutation | Non-synonymous JAK Family Gene Mutation | 0 |
C1335675::gene_involved_in_molecular_abnormality | gene_involved_in_molecular_abnormality | In which molecular abnormality is the gene {subj} involved? | C1335675 | Receptor Tyrosine Kinase Gene | C5447807 | ERBB2 NM_004448.3:c.2033G>A | CYP3A4 gene.c.6C>T | Point mutation in exon 21 (L858R) | ERBB2 NM_004448.3:c.2033G>A | NR5A1 gene mutation | 2 |
C0919528::gene_involved_in_molecular_abnormality | gene_involved_in_molecular_abnormality | In which molecular abnormality is the gene {subj} involved? | C0919528 | KMT2A gene | C1518132 | KMT2A-MLLT1 Fusion Protein Expression | CDX2 Protein Overexpression | KMT2A-MLLT1 Fusion Protein Expression | EGFR gene overexpression | Non-synonymous RAS Family Gene Mutation | 1 |
C1537502::gene_involved_in_pathogenesis_of_disease | gene_involved_in_pathogenesis_of_disease | In the pathogenesis of which disease is the gene {subj} involved? | C1537502 | KRAS gene | C1335167 | mucinous adenocarcinoma of ovary | mucinous adenocarcinoma of oral cavity | mucinous adenocarcinoma of ovary | mucinous adenocarcinoma of anal canal | mucinous adenocarcinoma of breast | 1 |
C0079419::gene_involved_in_pathogenesis_of_disease | gene_involved_in_pathogenesis_of_disease | In the pathogenesis of which disease is the gene {subj} involved? | C0079419 | TP53 gene | C1332166 | Adenocarcinoma of the gastroesophageal junction | Primary carcinoma of lower third of esophagus | Adenocarcinoma of the gastroesophageal junction | Adenocarcinoma of duodenum | Basal cell carcinoma of esophagus | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.